Global Glucose Monitoring Devices Market Segmented by Glucose Monitoring System, Application & Geography - Analysis, Growth, Trends & Forecast 2018-2023, With an Expected CAGR of 6.5% - ResearchAndMarkets.com

DUBLIN--()--The "Global Glucose Monitoring Devices Market - Segmented by Glucose Monitoring System, Application, and Geography - Growth, Trends, and Forecast (2018-2023)" report has been added to ResearchAndMarkets.com's offering.

The global glucose monitoring devices market is expected to register a CAGR of about 6.5% during 2018-2023 (the forecast period).

There have been continuous advances in the field of glucose monitoring over the last four decades, which have led to the development of highly evolved blood glucose meters, non-invasive glucose monitoring (NGM) devices, and continuous glucose monitoring systems (CGMS). CGMS have led to tremendous improvements in the diabetic management, as shown by the significant lowering of glycated hemoglobin (HbA1c) in adults with Type I diabetes.

A laboratory is a crucial part of glucose monitoring. Laboratories have shifted from fee-for-service (FFS) to value-based reimbursement systems. Planned cuts in reimbursement rates are being made to the Centers for Medicare & Medicaid Services (CMS) that are responsible for healthcare insurance programs. Tests are reimbursed according to the Hospital Outpatient Prospective Payment System (OPPS), and are billed directly by the hospitals rather than the labs. Many labs are already affected by the transition in healthcare from FFS payments to value-based payments.

North America is expected to dominate the global market, due to the growing demand for a prompt and accurate diagnosis, treatment, and the presence of technically advanced healthcare infrastructure.

Companies Mentioned

  • Abbott Laboratories
  • Lifescan Inc.
  • F. Hoffmann-La Roche AG
  • Bayer Healthcare AG
  • Medtronic Inc.
  • Dexcom Inc.
  • Arkay Inc.
  • Insulet Corporation
  • Novo Nordisk A/S
  • Terumo Corporation

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of The Market

For more information about this report visit https://www.researchandmarkets.com/research/vv964g/global_glucose?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Medical Devices, Glucose Testing, Diabetes Devices

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Medical Devices, Glucose Testing, Diabetes Devices